Strategic Analysis Of The Global Clinical Nutrition for Cancer Care Market 2024 – 2033

July 18, 2024 06:16 PM AEST | By EIN Presswire
 Strategic Analysis Of The Global Clinical Nutrition for Cancer Care Market 2024 – 2033
Image source: EIN Presswire

LANDON, GREATER LANDON, UK, July 18, 2024 /EINPresswire.com/ -- The global clinical nutrition for cancer care market is projected to grow from $4.67 billion in 2023 to $4.92 billion in 2024, at a CAGR of 5.5%. Despite various challenges, the market is anticipated to reach $6.14 billion by 2028 at a CAGR of 5.7%, driven by increasing awareness of nutritional needs, precision nutrition approaches, and advancements in cancer treatment.

Rising Prevalence of Cancer Propels Market Growth
The rising prevalence of cancer significantly contributes to the growth of the clinical nutrition for cancer care market. Cancer, characterized by uncontrolled cell growth and potential spread, is on the rise due to increased life expectancy, making the aging population more susceptible. Clinical nutrition provides specialized dietary management tailored to cancer patients, optimizing treatment outcomes. For instance, according to the World Health Organization, approximately 35 million new cancer cases are predicted in 2050, a 77% increase from 2022.

Explore comprehensive insights into the global clinical nutrition for cancer care market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=16017&type=smp

Major Players and Market Trends
Key players such as Pfizer Inc., Bayer AG, and Abbott Nutrition are developing innovative products like oral nutritional supplements to gain a competitive edge. For example, in July 2022, Nestle launched China's First Foods Oral Impact Su Yi Su, a nutritional supplement designed for patients with tumor-related conditions, following a five-year approval process.

Trends in Nutritional Biomarker Research and Technology
The forecast period is expected to witness significant trends, including advances in nutritional biomarker research and technological innovations in nutritional products and delivery systems. Increased collaboration between oncologists and advancements in nutritional science are also prominent trends shaping the market.

Segments:
• Type: Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas
• Cancer Type: Head And Neck Cancer, Stomach And Gastrointestinal Cancers, Blood Cancer, Breast Cancer, Lung Cancer, Other Cancer Types
• Age Group: Adult, Pediatric
• Sales Channel: Online, Retail, Institutional Sales

Geographical Insights: North America Leading the Market
North America was the largest region in the clinical nutrition for cancer care market in 2023. The comprehensive report provides detailed insights into regional dynamics, market trends, and growth opportunities.

Explore the report store to make a direct purchase of the report
https://www.thebusinessresearchcompany.com/report/clinical-nutrition-for-cancer-care-global-market-report

Clinical Nutrition For Cancer Care Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Clinical Nutrition For Cancer Care Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on clinical nutrition for cancer care market size, clinical nutrition for cancer care market drivers and trends, clinical nutrition for cancer care market major players, competitors' revenues, market positioning, and market growth across geographies. The clinical nutrition for cancer care market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Clinical Nutrition Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/clinical-nutritions-global-market-report

Nutritional Analysis Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nutritional-analysis-global-market-report

Parenteral Nutrition Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports covering 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.